Affiliation:
1. School of Pharmacy, Faculty of Medical and Health Sciences The University of Auckland Auckland New Zealand
2. Department of Psychological Medicine, School of Medicine The University of Auckland Auckland New Zealand
3. Department of Pharmaceutical and Administrative Sciences University of Health Sciences and Pharmacy St. Louis Missouri USA
Abstract
AbstractObjectivesOpioid use has increased globally, dramatically increasing opioid overdose, dependence, abuse and mortality. Limited research is available on opioid use patterns in older adults in New Zealand and internationally. This study aims to address this gap by determining the incidence and prevalence of opioid use among older adults (age ≥65 years) in New Zealand from 2007 to 2018.MethodsThis was a population‐based retrospective cohort study conducted using New Zealand national administrative healthcare databases. The annual opioid use incidence (2008–2018) and prevalence (2007–2018) in older adults were determined and stratified by sex, age, and opioid type and strength. We used descriptive statistics to summarise the patterns of opioid dispensing. Data analysis was conducted using MS Excel, and data linking was performed using SQL software.ResultsA total of 820,349 older adults were initiated on opioids during the study period. The overall incidence of opioid use in older adults showed a steady increase from 2008 to 2015; similarly, the prevalence steadily increased from 2007 to 2015, and thereafter, both rates fluctuated. A slight decrease in both prevalence and incidence rates was observed in 2018. Codeine and tramadol were the most commonly dispensed opioids during the study period. Females had a higher incidence and prevalence of all opioids than males.ConclusionsThe incidence and prevalence of opioid dispensing increased in New Zealand older adults over time. Monitoring the trends of opioid use in older adults is critical to enable clinicians and policymakers to deliver early interventions to prevent future opioid‐related adverse events.
Reference30 articles.
1. Predictors of persistent prescription opioid analgesic use among people without cancer in Australia
2. Health Quality and Safety Commission (HQSC).Opioids. Accessed December 3 2021.https://www.hqsc.govt.nz/our‐programmes/health‐quality‐evaluation/projects/atlas‐of‐healthcare‐variation/opioids/
3. The Effectiveness and Risks of Long-Term Opioid Therapy for Chronic Pain: A Systematic Review for a National Institutes of Health Pathways to Prevention Workshop
4. MedSafe.Options for minimising opioid abuse misuse and dependence. Accessed June 10 2021.https://www.medsafe.govt.nz/committees/marc/reports/186‐3.2.3‐Opioid.pdf
5. New Zealand Formulary (NZF).NZFv135: morphine salts. Accessed September 1 2023.https://nzf.org.nz/nzf_2515